Mark Sheptoff Financial Planning, LLC Abbott Laboratories Transaction History

Mark Sheptoff Financial Planning, LLC

  • $197 Million
  • Q3 2025

A detailed history of Mark Sheptoff Financial Planning, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Mark Sheptoff Financial Planning, LLC holds 42,468 shares of ABT stock, worth $5.52 Million. This represents 2.88% of its overall portfolio holdings.

Number of Shares
42,468
Previous 42,547 0.19%
Holding current value
$5.52 Million
Previous $5.79 Million 1.69%
% of portfolio
2.88%
Previous 3.21%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
SELL
$120.51 - $136.62 $9,520 - $10,792
-79 Reduced 0.19%
42,468 $5.69 Million
Q2 2025

Aug 06, 2025
BUY
$123.95 - $138.08 $4,586 - $5,108
37 Added 0.09%
42,547 $5.79 Million
Q1 2025

May 13, 2025
SELL
$111.1 - $140.22 $11,110 - $14,022
-100 Reduced 0.23%
42,510 $5.64 Million
Q4 2024

Feb 11, 2025
SELL
$111.93 - $119.39 $16,789 - $17,908
-150 Reduced 0.35%
42,610 $4.82 Million
Q2 2024

Aug 12, 2024
SELL
$100.73 - $112.44 $157,843 - $176,193
-1,567 Reduced 3.54%
42,760 $4.44 Million
Q1 2024

May 10, 2024
SELL
$109.52 - $120.96 $57,498 - $63,504
-525 Reduced 1.17%
44,327 $5.04 Million
Q4 2023

Feb 09, 2024
SELL
$90.19 - $110.4 $54,114 - $66,240
-600 Reduced 1.32%
44,852 $4.94 Million
Q3 2023

Nov 09, 2023
SELL
$95.53 - $114.62 $353,461 - $424,094
-3,700 Reduced 7.53%
45,452 $4.4 Million
Q2 2023

Aug 10, 2023
SELL
$100.78 - $112.29 $246,810 - $274,998
-2,449 Reduced 4.75%
49,152 $5.36 Million
Q1 2023

May 11, 2023
SELL
$96.86 - $114.01 $29,058 - $34,203
-300 Reduced 0.58%
51,601 $5.23 Million
Q4 2022

Feb 14, 2023
SELL
$95.06 - $111.52 $97,341 - $114,196
-1,024 Reduced 1.93%
51,901 $5.7 Million
Q3 2022

Nov 08, 2022
SELL
$96.76 - $112.03 $208,034 - $240,864
-2,150 Reduced 3.9%
52,925 $5.12 Million
Q2 2022

Aug 11, 2022
SELL
$102.07 - $123.37 $148,001 - $178,886
-1,450 Reduced 2.57%
55,075 $5.98 Million
Q1 2022

May 12, 2022
SELL
$114.02 - $139.04 $11,402 - $13,904
-100 Reduced 0.18%
56,525 $6.69 Million
Q4 2021

Feb 11, 2022
BUY
$115.53 - $141.46 $115 - $141
1 Added 0.0%
56,625 $7.97 Million
Q3 2021

Nov 10, 2021
SELL
$116.66 - $129.06 $64,279 - $71,112
-551 Reduced 0.96%
56,624 $6.69 Million
Q2 2021

Aug 12, 2021
SELL
$105.79 - $124.53 $88,863 - $104,605
-840 Reduced 1.45%
57,175 $6.63 Million
Q4 2020

Feb 11, 2021
BUY
$105.0 - $114.42 $44,625 - $48,628
425 Added 0.74%
58,015 $6.35 Million
Q3 2020

Nov 12, 2020
BUY
$91.64 - $111.29 $8,247 - $10,016
90 Added 0.16%
57,590 $6.27 Million
Q2 2020

Aug 10, 2020
SELL
$76.57 - $98.0 $30,781 - $39,396
-402 Reduced 0.69%
57,500 $5.26 Million
Q1 2020

May 07, 2020
BUY
$62.82 - $91.86 $451,047 - $659,554
7,180 Added 14.16%
57,902 $4.57 Million
Q4 2019

Feb 10, 2020
SELL
$78.51 - $87.4 $62,729 - $69,832
-799 Reduced 1.55%
50,722 $4.41 Million
Q3 2019

Nov 12, 2019
BUY
$81.84 - $88.74 $69,727 - $75,606
852 Added 1.68%
51,521 $4.31 Million
Q2 2019

Aug 12, 2019
BUY
$72.88 - $85.0 $145,905 - $170,170
2,002 Added 4.11%
50,669 $4.26 Million
Q1 2019

May 10, 2019
BUY
$66.22 - $80.06 $76,351 - $92,309
1,153 Added 2.43%
48,667 $3.89 Million
Q4 2018

Feb 11, 2019
BUY
$65.56 - $74.27 $94,078 - $106,577
1,435 Added 3.11%
47,514 $3.44 Million
Q3 2018

Nov 13, 2018
BUY
$60.81 - $73.36 $106,721 - $128,746
1,755 Added 3.96%
46,079 $3.38 Million
Q2 2018

Aug 09, 2018
SELL
$57.57 - $63.54 $11,226 - $12,390
-195 Reduced 0.44%
44,324 $2.7 Million
Q1 2018

May 08, 2018
BUY
$56.27 - $63.62 $24,758 - $27,992
440 Added 1.0%
44,519 $2.67 Million
Q4 2017

Feb 09, 2018
SELL
$53.68 - $57.47 $21,203 - $22,700
-395 Reduced 0.89%
44,079 $2.52 Million
Q3 2017

Nov 09, 2017
BUY
$48.06 - $53.64 $2.14 Million - $2.39 Million
44,474
44,474 $2.37 Million

Others Institutions Holding ABT

# of Institutions
3,650
Shares Held
1.38B
Call Options Held
10.3M
Put Options Held
9.01M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Mark Sheptoff Financial Planning, LLC Portfolio

Follow Mark Sheptoff Financial Planning, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mark Sheptoff Financial Planning, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mark Sheptoff Financial Planning, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email